Abstract:BACKGROUND: Diverse clinical and serological manifestations of systemic lupus erythematosus (SLE) compromise its diagnosis and treatment. A more reliable biomarker for SLE, which can play a critical role in either diagnosis, monitoring the disease progress or evaluating the response to treatment for individualized therapeutic, is necessary. DNA sensor is an important mediator of inflammation in systemic autoimmune diseases. However, the potential role for DNA sensor as disease activity biomarkers for SLE remained obscure. We detected the aberrant activation of DNA sensors and the corresponding IFN-β response in SLE patients, and to evaluate their potential role as disease biomarkers for SLE.METHODS: We quantified the expressions of IFN-I and DNA sensor, such as cGAS, IFI16, DDX41, DAI and their down-stream adaptor STING in PBMC derived from patients with SLE (n = 100), healthy controls (HCs) (n = 62) by real-time PCR. The relationships between the expression of cGAS or IFI16 and clinical features in SLE patients were investigated. ROC curve analysis was performed to examine the predictive value of cGAS and IFI16 in SLE diagnosis, disease activity monitoring, specific organ manifestation and therapeutic response. RNA interference-mediated depletion of IFI16 or cGAS was conducted to evaluate their impact on IFN-I response.RESULTS: The expressions of cGAS and IFI16 were significantly higher in PBMC from SLE patients, closely correlated with the SLEDAI scores and high anti-dsDNA antibody titers. While the AUC for cGAS (0.767) was less than that of IFI16 and IFN-β, the AUC for IFI16 (0.856) and IFN-β (0.856) were similar. Expression of cGAS and IFI16 combine with IFN-β in PBMC showed high sensitivity (89.2%) and specificity (89.1%) for discrimination between mild and moderate/severe disease activity in SLE. Higher expression of IFI16 was association with ocular disorder in SLE patients. Neither IFI16 nor cGAS was a reliable indicator of therapeutic response. RNA interference-mediated depletion of IFI16 or cGAS prevented active SLE serum-induced upregulating in both IFN-α and IFN-β.CONCLUSIONS: High expression levels of cGAS and IFI16 in PBMC from SLE patients correlated strongly with disease activity. Both cGAS and IFI16 mediated signaling pathway were account for the robust production of IFN-β. Expression of cGAS and IFI16 combined with IFN-β in PBMC might serve as potential biomarkers for early diagnosis and monitoring disease activity in SLE.

[Using GST-tag to Capture Protein Interaction of an Interferon-Inducible Systemic Lupus Associated Gene, IFIT1].

Protein Interaction for an Interferon-Inducible Systemic Lupus Associated Gene, IFIT1

Effect of IFIT3 Gene in the Pathogenesis of Systemic Lupus Erythematosus and Construction of Its Eukaryotic Expression Plasmid

Expressions of interferon-inducible genes in patients with systemic lupus erythematosus and their assoc-iation with disease activity

[Interferon-Inducible Genes Lymphocyte Antigen 6 Complex E and Tetratricopeptide Repeats 1 Are Correlated with Clinical Features of Patients with Systemic Lupus Erythematosus].

329 Elevated ifit3 in monocytes contributed to hyperactive cgas-sting signalling pathway in sle

Interferon-induced Protein IFIT4 is Associated with Systemic Lupus Erythematosus and Promotes Differentiation of Monocytes into Dendritic Cell-Like Cells

Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus

Association of Abnormal Elevations in IFIT3 with Overactive Cyclic GMP‐AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes

Identification of IFITM3 as a diagnostic biomarker of systemic lupus erythematosus and its association with disease activity based on multi-omics and experimental verification

Sequential Activation of Protein Kinase C Δ and JNK is Required for Interferon-Α-induced Expression of IFIT4

Increased interferon-inducible gene expression, an useful marker in the diagnosis and disease activity evaluation of systemic lupus erythematosus

The expression levels of interferon inducible genes in peripheral blood cells and their correlation with clinical features in human systemic lmpus erytbematosus

Effects of Systemic Lupus Erythematosus Susceptible Gene IFIT1 on Chemokine Expression in Mouse Macrophage Cells

Structural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosus

Identification of Interferon-Inducible Genes As Diagnostic Biomarker for Systemic Lupus Erythematosus

Structural Basis for Inhibition of Interferon Alpha Signaling Pathway and Its Therapeutic Potential in SLE Patients

The role of cyclic GMP-AMP synthase and Interferon-I-inducible protein 16 as candidatebiomarkers of systemic lupus erythematosus

[Peripheral Blood Mrna and Interferon Gene Expression in Systemic Lupus Erythematosus].

LB760 Upregulation of IFI44L Induces Inflammation by Activating TBK1/IRF3 Pathway in Systemic Lupus Erythematosus

Identification and Validation of IFI44 As Key Biomarker in Lupus Nephritis.